Dapagliflozin Lowers Cardiovascular Risks, Uric Acid Regardless of Gout Status

Investigators examined outcomes and use of uric-acid lowering therapies among patients taking dapagliflozin for heart failure with and without gout.

Related Keywords

United Kingdom ,British ,Johnjv Mcmurray , ,Astrazeneca ,British Heart Foundation Cardiovascular Research Centre ,University Of Glasgow ,